Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease

References

• Balali-MoodMHefaziMComparison of early and late toxic effects of sulfur mustard in Iranian veteransBasic Clin Pharmacol Toxicol20069927328217040211
   PubMed Web of Science ®Google Scholar
• GhaneiMAdibiIClinical review of mustard lungIran J Med Sci2007325865
   Google Scholar
• WattanaMBeyTMustard gas or sulfur mustard: An old chemical agent as new terrorist threatPrehosp Disaster Med200924192919557954
   PubMedGoogle Scholar
• GhaneiMAmiriSAkbariHCorrelation of sulfur mustard exposure and tobacco use with expression (immunoreactivity) of p53 protein in bronchial epithelium of Iranian “mustard lung” patientsMil Med2007172707417274270
   PubMed Web of Science ®Google Scholar
• Balali-MoodMHefaziMMahmoudiMLong-term complications of sulfur mustard poisoning in severely intoxicated Iranian veteransFundam Clin Pharmacol20051971372116313284
   PubMed Web of Science ®Google Scholar
• KhateriSGhaneiMKeshavarzSSoroushMHainezDIncidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agentJ Occup Environ Med2003451136114314610394
   PubMed Web of Science ®Google Scholar
• JafariMGhaneiMEvaluation of plasma, erythrocytes, and bronchoalveolar lavage fluid antioxidant defense system in sulfur mustard-injured patientsClin Toxicol (Phila).20104818419220397800
   PubMed Web of Science ®Google Scholar
• WigenstamERocksénDEkstrand-HammarströmBBuchtATreatment with dexamethasone or liposome-encapsuled vitamin E provides beneficial effects after chemical-induced lung injuryInhal Toxicol20092195896419572781
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCaleverleyPMJenkinsCRHurdSSGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for Obstructive Lung Disease (GOLD) workshop summaryAm J Respir Crit Care Med20011631256127611316667
   PubMedGoogle Scholar
• SinDDPaul ManSFInterleukin-6Chest20081334618187736
   PubMed Web of Science ®Google Scholar
• YanbaevaDGDentenerMASpruitMAIL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: A case- control studyBMC Med Genet2009102319272152
   PubMed Web of Science ®Google Scholar
• GanWQManSFSenthilselvanASinDDAssociation between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and meta analysisThorax20045957458015223864
   PubMed Web of Science ®Google Scholar
• HeJQForemanMGShumanskyKAssociations of IL6 polymorphisms with lung function decline and COPDThorax20096469870419359268
   PubMed Web of Science ®Google Scholar
• KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung200818640340918807087
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest20051281995200416236847
   PubMed Web of Science ®Google Scholar
• GarrodRMarshallJBarleyEThe relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)Prim Care Respir J20071623624017665081
   PubMedGoogle Scholar
• YendeSWatererGWTolleyEAInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax200661101616284220
   PubMed Web of Science ®Google Scholar
• EmadAEmadYLevels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalationJ Interferon Cytokine Res200727384317266442
   PubMed Web of Science ®Google Scholar
• AttaranDLariSMKhajehdalueeMHighly sensitive C-reactive protein levels in Iranian patients with pulmonary complication of sulfur mustard poisoning and its correlation with severity of airway diseasesHum Exp Toxicol20092873974519919970
   PubMed Web of Science ®Google Scholar
• PourfarzamSGhazanfariTYaraeeRSerum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort StudyInt Immunopharmacol200991482148819748599
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyStandards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199552S77S121
   Google Scholar
• JonesPWSpencerSAdieSThe St George’s Respiratory Questionnaire ManualLondonRespiratory Medicine, St George’s Hospital Medical School2003
   Google Scholar
• HalvaniAPourfarokhPNasirianiKQuality of life and related factors in patients with chronic obstructive pulmonary diseaseTanaffos200655156
   Google Scholar
• CelliBRCoteCGMarinJMThe body mass index, airflow obstruction, dyspnea and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med20043501005101214999112
   PubMed Web of Science ®Google Scholar
• American Thoracic SocietyATS statement: Guidelines for the six-minute walk testAm J Respir Crit Care Med200216611112912091180
   PubMed Web of Science ®Google Scholar
• WoodLGWarkPAGargMLAntioxidant and antiinflammatory effects of resveratrol in airway diseaseAntioxid Redox Signal2010526 [Epub ahead of print]
   Web of Science ®Google Scholar
• RahmanIThe role of oxidative stress in the pathogenesis of COPD: Implications for therapyTreat Respir Med2005417520015987234
   PubMedGoogle Scholar
• CavalcanteAGde BruinPFThe role of oxidative stress in COPD: Current concepts and perspectivesJ Bras Pneumol2009351227123720126926
   PubMed Web of Science ®Google Scholar
• MacNeeWPathogenesis of chronic obstructive pulmonary diseaseClin Chest Med20072847951317720039
   PubMed Web of Science ®Google Scholar
• SevenoaksMJStockleyRAChronic obstructive pulmonary disease, inflammation and co-morbidity – a common inflammatory phenotypeRespir Res20067707816669999
   PubMed Web of Science ®Google Scholar
• BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J2009331165118519407051
   PubMed Web of Science ®Google Scholar
• GhaneiMTazelaarHDChilosiMAn international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patientsRespir Med200810282583018339530
   PubMed Web of Science ®Google Scholar
• ShohratiMGhaneiMShamspourNErratum to: Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxicationLung2010188778319862574
   PubMed Web of Science ®Google Scholar
• GhaneiMShohratiMJafariMGhaderiSAlaeddiniFAslaniJN-acetylcysteine improves the clinical conditions of mustard gasexposed patients with normal pulmonary function testBasic Clin Pharmacol Toxicol200810342843218801028
   PubMed Web of Science ®Google Scholar
• KumarOSugendranKVijayaraghavanRProtective effect of various antioxidants on the toxicity of sulfur mustard administered to mice by inhalation or percutaneous routesChem Biol Interact200113411211248218
   PubMed Web of Science ®Google Scholar
• VijayaraghavanRGautamAKumarOProtective effect of ethanolic and water extracts of sea buckthorn (Hippophae rhamnoides L.) against the toxic effects of mustard gasIndian J Exp Biol20064482183117131913
   PubMedGoogle Scholar
• MacNeeWOxidants/antioxidants and COPDChest2000117S303S317
   Web of Science ®Google Scholar
• SinDDManSFSkeletal muscle weakness, reduced exercise tolerance, and COPD: Is systemic inflammation the missing linkThorax200661316396949
   PubMed Web of Science ®Google Scholar
• AttaranDKhajedalouiMJafarzadehRMazloomiMHealth related quality of life in patients with chemical warfare induced COPDArchives of Iranian Medicine2006935936317061610
   PubMedGoogle Scholar
• SinDDManSFMarciniukDDThe effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20081771207121418310480
   PubMed Web of Science ®Google Scholar
• AntoniuSASystemic inflammation and inhaled corticosteroids in COPDAm J Respir Crit Care Med2009179170 Author reply 170–17119119152
   PubMed Web of Science ®Google Scholar